Randolph Simpson - Tenet Healthcare Independent Director
THC Stock | USD 97.86 3.01 3.17% |
Director
Mr. Randolph C. Simpson is an Independent Director of the Company. Mr. Simpson joined Glenview Capital Management, an investment fund, in September 2005 and was named a partner in April 2011. He is the cohead of Glenviews Healthcare team and oversees the Consumer team. Prior to joining Glenview, Mr. Simpson was an equity research analyst at Goldman Sachs from 2003 until 2005. Prior to his work at Goldman Sachs, Mr. Simpson spent three years in the MA group at Credit Suisse First Boston as a generalist. Mr. Simpson received his M.B.A. in finance and accounting from the University of Chicago in 2000, where he graduated Beta Gamma Sigma since 2016.
Age | 46 |
Tenure | 8 years |
Address | 14201 Dallas Parkway, Dallas, TX, United States, 75254 |
Phone | 469 893 2200 |
Web | https://www.tenethealth.com |
Tenet Healthcare Management Efficiency
The company has Return on Asset of 0.0629 % which means that on every $100 spent on assets, it made $0.0629 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2592 %, implying that it generated $0.2592 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.6 M, whereas Intangible Assets are forecasted to decline to about 1.4 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
Carol Davidson | DaVita HealthCare Partners | 60 | |
Pascal Desroches | DaVita HealthCare Partners | 55 | |
Malene Davis | The Ensign Group | 55 | |
Mark First | Addus HomeCare | 53 | |
Nancy Schlichting | Encompass Health Corp | 66 | |
Rita JohnsonMills | Brookdale Senior Living | 61 | |
Matthew Lozow | Surgery Partners | 37 | |
Russell Carson | Select Medical Holdings | 77 | |
Ann Lamont | HCA Holdings | 58 | |
William Petty | Brookdale Senior Living | 70 | |
Andrew Kaplan | Surgery Partners | 33 | |
Harold Paz | Select Medical Holdings | 62 | |
Wade Miquelon | Acadia Healthcare | 53 | |
William Grieco | Acadia Healthcare | 64 | |
Kyle Lattner | Acadia Healthcare | 29 | |
Chris Gordon | Acadia Healthcare | 44 | |
Michael Johns | AMN Healthcare Services | 78 | |
Joan Herman | Encompass Health Corp | 67 | |
Jean Rush | Addus HomeCare | 60 | |
William Frist | HCA Holdings | 51 | |
William Roper | DaVita HealthCare Partners | 69 |
Management Performance
Return On Equity | 0.26 | ||||
Return On Asset | 0.0629 |
Tenet Healthcare Leadership Team
Elected by the shareholders, the Tenet Healthcare's board of directors comprises two types of representatives: Tenet Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenet. The board's role is to monitor Tenet Healthcare's management team and ensure that shareholders' interests are well served. Tenet Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenet Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Johnston, Chief USPI | ||
Richard Pettingill, Independent Director | ||
Nadja West, Independent Director | ||
Paola Arbour, Executive Vice President, Chief Information Officer | ||
William III, Vice Relations | ||
J Kerrey, Lead Independent Director | ||
Robert Kerrey, Independent Director | ||
Brenda Gaines, Independent Director | ||
Sun Park, Executive CFO | ||
Michael Maloney, Executive Development | ||
John Byrnes, Independent Director | ||
Edward Kangas, Independent Chairman of the Board | ||
James Bierman, Independent Director | ||
Thomas Arnst, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary | ||
Daniel Cancelmi, Chief Financial Officer, Executive Vice President | ||
Audrey Andrews, Executive Vice President, General Counsel, Corporate Secretary | ||
Ronald Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer | ||
Jana Durfee, Senior Officer | ||
Brendan Strong, Chief Financial Officer | ||
Ernest Franklin, Chief Medical Operations Officer | ||
Meghan FitzGerald, Independent Director | ||
Bill Durham, Chief Network | ||
Tim Adams, Senior Vice President - Operations and Integration | ||
Christopher Lynch, Independent Director | ||
Cecil Haney, Independent Director | ||
Liz Johnson, Chief Officer | ||
Richard Fisher, Independent Director | ||
Britt Reynolds, President of Hospital Operations | ||
Howard Hacker, Executive Vice President, Chief Compliance Officer | ||
Lloyd Austin, Independent Director | ||
Trevor Fetter, Chairman, CEO and President and Member of Executive Committee | ||
Richard Mark, Independent Director | ||
Lisa Foo, Executive Vice President - Commercial Operations | ||
Karen Garrison, Independent Director | ||
Peter Wilver, Independent Director | ||
Tammy Romo, Independent Director | ||
James Unruh, Independent Director | ||
Randolph Simpson, Independent Director | ||
Freda LewisHall, Independent Director | ||
Robert Webb, Chief Human Resource Officer, Senior Vice President | ||
Matthew Ripperger, Independent Director | ||
Saumya Sutaria, President, Chief Executive Officer, Chief Operating Officer, Director | ||
Regina Nethery, Vice President of Investor Relations | ||
Keith Pitts, Vice Chairman | ||
Saumya MD, CEO and President | ||
Sandra Karrmann, Chief Human Resource Officer, Executive Vice President | ||
Marie Quintana, Executive Vice President - Communications, Chief Marketing Officer | ||
Eric Evans, President - Hospital Operations | ||
Clint Hailey, Chief VP |
Tenet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenet Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.26 | ||||
Return On Asset | 0.0629 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 28.2 B | ||||
Shares Outstanding | 99.19 M | ||||
Shares Owned By Insiders | 1.30 % | ||||
Shares Owned By Institutions | 97.81 % | ||||
Number Of Shares Shorted | 4.26 M | ||||
Price To Earning | 11.95 X |
Tenet Healthcare Investors Sentiment
The influence of Tenet Healthcare's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tenet. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tenet Healthcare's public news can be used to forecast risks associated with an investment in Tenet. The trend in average sentiment can be used to explain how an investor holding Tenet can time the market purely based on public headlines and social activities around Tenet Healthcare. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tenet Healthcare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tenet Healthcare's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tenet Healthcare's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tenet Healthcare.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tenet Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tenet Healthcare's short interest history, or implied volatility extrapolated from Tenet Healthcare options trading.
Currently Active Assets on Macroaxis
When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.Note that the Tenet Healthcare information on this page should be used as a complementary analysis to other Tenet Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Tenet Stock analysis
When running Tenet Healthcare's price analysis, check to measure Tenet Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenet Healthcare is operating at the current time. Most of Tenet Healthcare's value examination focuses on studying past and present price action to predict the probability of Tenet Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenet Healthcare's price. Additionally, you may evaluate how the addition of Tenet Healthcare to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Tenet Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.403 | Earnings Share 5.71 | Revenue Per Share 202.166 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0629 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.